# Phase 1 Clinical Trial of DA-5207 in Healthy Adults

> **NCT05127746** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 51 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Aricept 5mg Tablet
- **DRUG:** Aricept 10mg Tablet
- **DRUG:** DA-5207 A
- **DRUG:** DA-5207 B

## Key facts

- **NCT ID:** NCT05127746
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-25
- **Primary completion:** 2022-12-13
- **Final completion:** 2022-12-13
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2023-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05127746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05127746, "Phase 1 Clinical Trial of DA-5207 in Healthy Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05127746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*